Can I drink alcohol while taking ritexitinib? Analysis of the impact of alcohol on medicinal efficacy

Ritlecitinib is a Janus kinase (JAK) and TEC kinase inhibitor, mainly used to treat severe alopecia areata (Alopecia Areata). Patients should avoid drinking alcohol while taking ritexitinib, as alcohol may have adverse effects on the metabolism and efficacy of the drug, as well as the patient's overall health.

First of all, ritexitinib is mainly metabolized by the liver, while alcohol also relies on liver decomposition. The simultaneous action of both may increase the burden on the liver, increase liver enzyme levels, and even lead to abnormal liver function. Especially for long-term drinkers, the metabolic capacity of the liver may change, thereby affecting the metabolism rate of the drug in the body, which may reduce the efficacy of the drug or increase the risk of adverse reactions.

Second, alcohol may enhance the adverse effects of drugs. Common side effects of ritixitinib include headache, nausea, diarrhea, and fatigue, and alcohol itself may cause similar symptoms. The interaction between the two may aggravate these discomforts, making patients more likely to suffer from fatigue, decreased concentration and other problems during the treatment process, affecting daily life and work.

In addition, alcohol may affect the function of the immune system. Ritexitinib itself has an immunomodulatory effect and may affect the body's immune response, and alcohol intake may further weaken the immune system, making patients more susceptible to infection. Therefore, patients who are taking ritixitinib, especially those on long-term treatment, should avoid drinking alcohol as much as possible to reduce the risk of infection and ensure the maximum efficacy of the drug.

Research shows that alcohol may interfere with the absorption and distribution of certain drugs, affecting the blood concentration of the drug, thereby changing its therapeutic effect. Although there are currently no clear studies showing the specific interaction between ritexitinib and alcohol, in order to ensure the best therapeutic effect, it is recommended that patients avoid drinking alcohol while taking the drug, especially high-concentration alcoholic beverages such as spirits.

Reference materials:https://www.litfulo.com/